Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 2, 2018
Intraductal papillary mucinous neoplasms of the pancreas - a cost-effectiveness analysis of management strategies for the branch-duct subtypeLinus Aronsson, Daniel Ansari, Bodil Andersson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 20, 2010
The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in SwedenMichael Willis, Marianne Svensson, Mickael Löthgren, et al.
Kidney & Blood Pressure Research|December 21, 2013
A candidate gene approach to ANCA-associated vasculitis reveals links to the C3 and CTLA-4 genes but not to the IL1-Ra and Fcγ-RIIa genesUlf Persson, Birgitta Gullstrand, Asa Pettersson, et al.
Scandinavian Journal of Urology|April 26, 2016
Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in SwedenJohanna Svensson, Emelie Andersson, Ulf Persson, et al.
Pharmacoeconomics - Open|August 12, 2020
The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of DevelopmentAdam Fridhammar, Ulrika Axelsson, Ulf Persson, et al.
Health Policy (Amsterdam, Netherlands)|August 15, 2006
Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in SwedenAlf Tunsäter, Mikael Moutakis, Sixten Borg, et al.
Parkinsonism & Related Disorders|June 27, 2006
Estimating the value of novel interventions for Parkinson's disease: an early decision-making model with application to dopamine cell replacementJonas Hjelmgren, Ola Ghatnekar, Jan Reimer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
Obesity, survival, and hospital costs-findings from a screening project in SwedenSixten Borg, Ulf Persson, Knut Odegaard, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 11, 2012
Societal value of stem cell therapy in stroke--a modeling studyJohanna Svensson, Ola Ghatnekar, Arne Lindgren, et al.
Acta Neurologica Scandinavica|April 26, 2021
Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementationJenny M Norlin, Michael Willis, Ulf Persson, et al.
Pageof 10